Clinical Trials Directory

Trials / Unknown

UnknownNCT05194696

Caffeine Consumption and Cataract Prevention

The Impact of Caffeine Consumption on Preventing Cataract

Status
Unknown
Phase
Study type
Observational
Enrollment
12,000 (estimated)
Sponsor
Vienna Institute for Research in Ocular Surgery · Academic / Other
Sex
All
Age
21 Years – 105 Years
Healthy volunteers
Not accepted

Summary

Effect of peroral caffeine consumption on the delay of cataract onset.

Detailed description

Several experimental studies have shown that caffeine inhibits cataract development by scavenging reactive oxygen species. Evidence from epidemiological studies, however, is controversial. Varma et al., found that the incidence of cataract blindness in humans was significantly lower in groups consuming higher amounts of coffee in comparison to the groups with lower coffee intake. Moreover, Rautiainen et al. showed that the dietary total antioxidant capacity including coffee of middle-aged and elderly women was inversely associated with the risk of age-dependent cataract. Another population-based study involving the population residing in Beaver Dam, Wisconsin, did not find a meaningful association between 10-year cumulative incidence of cataract and the amount of caffeine intake. Although cataracts can be surgically removed, barriers that prevent access to surgery are a problem in many countries. Moreover, no prophylactic treatments are currently available to prevent the onset of cataract. Yet estimates indicate that a delay of only 10 years in the onset of cataract could reduce the need for cataract surgery by as much as 50%. The present study aims to investigate whether peroral caffeine consumption on a regular daily basis for a significant period of time and sufficient dose delays cataract development. 12000 eyes of 6000 patients will be included into this study. Patient will have to fill out a questionnaire for caffeine consumption habits during lifetime and risk factors for cataract development. Further, a complete ophthalmic examination, cataract grading, refraction, visual testing, and biometry will be performed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnairePatients have to answer a questionnaire about their caffeine consumption habits during lifetime

Timeline

Start date
2020-09-01
Primary completion
2024-09-01
Completion
2025-09-01
First posted
2022-01-18
Last updated
2022-01-31

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT05194696. Inclusion in this directory is not an endorsement.